DOC · Healthpeak Properties, Inc. · Financials

$18.98 +0.02 (+0.11%) At close · Oct 16

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$13.09B

689.53M

Volume · Oct 16 5.64M Avg daily vol (3M) 5.49M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →

Revenue

$2.82B +4.5%

FY2025

Net Income

$71.35M -70.7%

FY2025

Gross Margin

60.2% +1.6pp

FY2024

Diluted EPS

$0.10 -72.2%

FY2025

Operating Cash Flow

$1.25B +17%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow Adjusted All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007
Revenue	+11.0%	+11.4%	+3.8%	—	$2.95B	$2.82B	$2.7B	$2.18B	$2.06B	$1.9B	$1.64B	$1.24B	$1.19B	$1.85B	$2.13B	$1.94B	$1.64B	$2.1B	$1.88B	$1.69B	$1.24B	$1.15B	$1.14B	$953.74M
Rental Income	+11.8%	+12.8%	+6.8%	—	$2.16B	$2.16B	$2.09B	$1.63B	$1.54B	$1.38B	$1.18B	$1.07B	$1.02B	$1.21B	$1.16B	$1.12B	$1.15B	$1.13B	$997.77M	$986.43M	$904.33M	$876.34M	$867.37M	$759.81M
Cost of Revenue	+11.6%	+21.5%	—	—	$1.12B	—	$1.07B	$902.06M	$862.99M	$773.28M	$782.54M	$405.24M	$378.66M	$666.25M	$738.4M	—	—	—	—	—	—	—	—	—
Gross Profit	+13.1%	+14.2%	—	—	$1.68B	—	$1.63B	$1.28B	$1.2B	$1.12B	$862.33M	$835.1M	$812.66M	$1.18B	$1.39B	—	—	—	—	—	—	—	—	—
Gross Margin	—	—	—	—	—	—	60.2%	58.64%	58.13%	59.22%	52.43%	67.33%	68.22%	63.95%	65.32%	—	—	—	—	—	—	—	—	—
General & Administrative	-11.6%	-0.6%	-0.6%	—	$90.64M	$90.42M	$97.16M	$95.13M	$131.03M	$98.3M	$93.24M	$92.97M	$96.7M	$88.77M	$103.61M	$95.97M	$81.77M	$103.04M	$68.41M	$96.06M	$83.02M	$78M	$73.69M	$67.52M
Depreciation & Amortization	+14.2%	+13.8%	+7.7%	—	$1.1B	$1.06B	$1.06B	$749.9M	$710.57M	$684.29M	$553.95M	$435.19M	$404.68M	$534.73M	$568.11M	$504.91M	$455.02M	$423.31M	$353.7M	$346.06M	$306.93M	$315.95M	$312.01M	$258.26M
Impairment of Real Estate	—	—	—	—	$0	$0	—	$0	$0	—	—	—	—	—	—	$3.12M	—	—	$7.88M	—	—	—	$1.57M	—
Total Operating Expenses	+4.9%	+19.0%	+11.7%	—	$974.69M	—	—	$902.06M	$862.99M	$773.28M	$782.54M	$405.24M	$378.66M	$666.25M	$738.4M	$610.68M	$381.29M	$298.28M	—	—	—	—	—	—
Total Costs & Expenses	+11.3%	+8.8%	+3.6%	—	$2.8B	$2.61B	$2.67B	$1.96B	$1.89B	$1.74B	$1.71B	$1.17B	$1.15B	$1.77B	$1.88B	$1.83B	$1.37B	$1.27B	$1.14B	$1.22B	$873.72M	$1.05B	$945.26M	$501.49M
Interest Expense	+20.8%	+6.9%	-4.4%	—	$336.99M	$305.18M	$280.43M	$200.33M	$172.94M	$157.98M	$218.34M	$217.61M	$261.28M	$307.72M	$464.4M	$479.6M	$439.74M	$435.25M	$416.17M	$415.46M	$285.51M	$298.87M	$348.34M	$355.2M
Interest Income	+38.4%	+30.1%	-5.8%	—	$66.09M	$61.78M	$44.78M	$21.78M	$23.3M	$37.77M	$16.55M	$9.84M	$10.41M	$56.24M	$88.81M	$112.18M	$73.62M	$86.16M	$24.54M	$99.86M	$160.16M	$124.15M	$130.87M	$51.57M
Other Non-Operating Income	-40.7%	-24.3%	+12.0%	—	$295.95M	$69.97M	$238.04M	$93.27M	$335.35M	-$28.97M	$282.12M	$106.67M	$800.63M	$333.83M	$122.33M	$22.59M	$12.54M	$18.22M	$2.98M	$12.93M	$16.19M	$7.77M	$25.67M	-$320.66M
Equity in Earnings of Unconsolidated Entities	—	—	—	—	-$166.81M	-$173.98M	-$1.52M	$10.2M	$1.99M	$6.1M	-$66.6M	-$6.33M	-$5.76M	$10.9M	$11.36M	$6.59M	$49.57M	$64.43M	$54.46M	$46.75M	$4.77M	$3.51M	$3.33M	$5.65M
Investment Income (Loss)	—	-23.9%	—	—	$7.23M	—	—	—	—	—	—	—	—	—	—	—	$2.27M	$10.82M	-$43K	-$5.4M	$14.6M	$8.88M	-$7.23M	$2.23M
Pretax Income	-17.5%	+5.5%	+45.7%	—	$445.32M	$284.29M	$273.17M	$314.94M	$507.13M	$128.37M	$217.68M	-$8.63M	-$2.59M	$10.9M	$11.36M	$6.59M	-$3.61M	$852.02M	$745.08M	$490.68M	$382.68M	$101.04M	$225.4M	$131.59M
Income Tax	—	—	—	—	$3.67M	$9.28M	$4.35M	-$9.62M	-$4.43M	-$3.26M	-$9.42M	-$5.48M	-$4.4M	-$1.33M	$4.47M	-$9.81M	-$506K	$5.82M	-$1.65M	$1.3M	$412K	$1.91M	$4.22M	$1.44M
Net Income	-47.8%	-29.6%	—	—	$243.3M	$71.35M	$243.14M	$306.01M	$500.45M	$505.54M	$413.56M	$45.53M	$1.06B	$414.17M	$627.75M	-$559.24M	$922.23M	$970.84M	$832.54M	$538.89M	$330.71M	$131.69M	$448.5M	$614.12M
Net Margin	—	—	—	—	—	2.53%	9%	14.03%	24.28%	26.66%	25.14%	3.67%	89.07%	22.41%	29.48%	-28.82%	56.34%	46.23%	44.28%	31.8%	26.67%	11.48%	39.17%	64.39%
Net Income Attributable to Noncontrolling Interests	+6.1%	+0.2%	0.0%	—	$14.68M	—	—	—	—	—	—	$14.53M	$12.38M	$8.47M	$12.18M	$12.82M	$14.36M	$14.17M	$14.3M	$15.6M	$13.69M	$14.46M	$22.49M	$25.1M
Net Income Available to Common Stockholders	-47.9%	-29.7%	—	—	$242.74M	$70.51M	$242.38M	$304.28M	$497.79M	$502.27M	$411.15M	$43.99M	$1.06B	$413.01M	$626.55M	-$560.55M	$919.8M	$969.1M	$812.29M	$515.3M	$307.5M	$109.07M	$425.37M	$565.08M
Comprehensive Income	-60.6%	-39.8%	—	—	$258.85M	$32.59M	$252.59M	$297.25M	$531.73M	$506.08M	$412.74M	$47.38M	$1.08B	$419.79M	$628.58M	-$565.81M	$912.83M	$971M	$837.47M	$532.55M	$319.61M	$210.72M	—	—
EPS (Basic) USD/shares	-52.3%	-33.5%	—	—	$0.35	$0.10	$0.36	$0.56	$0.92	$0.93	$0.77	$0.09	$2.25	$0.88	$1.34	-$1.21	$2.01	$2.13	$1.90	$1.29	$1.01	$0.40	$1.79	$2.72
EPS (Diluted) USD/shares	-52.3%	-33.5%	—	$0.46 – $0.50	$0.35	$0.10^G	$0.36	$0.56	$0.92	$0.93	$0.77	$0.09	$2.24	$0.88	$1.34	-$1.21	$2.00	$2.13	$1.90	$1.29	$1.00	$0.40	$1.79	$2.70
Shares Outstanding (Basic Avg) shares	+8.9%	+5.6%	+4.2%	—	—	696.03M	675.68M	547.01M	538.81M	538.93M	530.56M	486.26M	470.55M	468.76M	467.2M	462.8M	458.43M	455M	427.05M	398.45M	305.57M	274.22M	237.3M	207.92M
Shares Outstanding (Diluted Avg) shares	+8.9%	+5.6%	+4.2%	—	—	696.04M	676.23M	547.28M	539.15M	539.24M	531.06M	489.34M	475.39M	468.94M	467.4M	462.8M	458.8M	455.7M	428.32M	400.22M	306.9M	274.63M	237.97M	208.92M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $428.95M in buybacks, $14.09B in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Long-term debt, including current maturities	2026-06-30	USD 10,032,186,000	10-Q filed 2026-08-05
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Secured debt, including current maturities USD 104,213,000 Unsecured debt, including current maturities USD 6,785,697,000
Operating lease liabilities	2026-06-30	USD 288,194,000	10-Q filed 2026-08-05

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

7.29×

Peer median 8.89×

EV/EBIT

—

P/E (TTM)

54.23×

Peer median 22.70×

P/FFO (FY2025)

10.49×

Peer median 22.08×

P/AFFO (FY2025)

11.23×

Peer median 12.87×

Peer medians compare against the 10 similar-size REIT - Healthcare Facilities companies (of 17 listed).

P/FFO and P/AFFO use the company-stated “Diluted Nareit FFO per common share” and “Diluted AFFO per common share”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.

Valuation over time computed as of each quarter's filing date

P/FFO and P/AFFO use the company-stated “Diluted Nareit FFO per common share” and “Diluted AFFO per common share”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Outpatient Medical	$1,273,505,000	$1,184,660,000	$732,279,000	$725,370,000	$671,242,000	$622,398,000	$621,171,000	$596,399,000
Lab	$860,020,000	$881,452,000	$878,326,000	$817,573,000	$715,844,000	$569,296,000	$440,784,000	$395,064,000
Senior Housing	$603,989,000	$568,475,000	$527,417,000	$494,935,000	$471,325,000	$436,494,000	$3,010,000	$0
Medical Office	—	—	—	—	—	—	$571,530,000	$547,375,000
Senior Housing Operating Portfolio	—	—	—	—	—	—	$725,171,000	$547,976,000
Senior Housing Triple Net	—	—	—	—	—	—	$199,441,000	$276,091,000
Other Non-Reporting Segment	—	—	$21,781,000	$23,300,000	$37,773,000	$16,687,000	$175,374,000	$199,857,000
All Other Segments	—	—	—	—	—	—	$175,374,000	$199,857,000

Key facts CIK 765880 CUSIP 42250P103 13F (30d) 113 filings 102 filers Visit website Investor relations